Tuesday, 31 January 2023

"Lab based Ab tests can enable increased expanse of COVID-19 testing"- Arpan Malhotra

12 June 2020 | Views

Arpan Malhotra, India Business Head - Diagnostics, Siemens Healthcare, Gurugram shares his thoughts on the ongoing COVID-19 situation

"Country is now moving towards a need for mass screening and community surveillance for COVID-19. Laboratory based antibody tests (CLIA) are not just higher in sensitivity, but are also scalable to very high throughputs. This can enable an increased expanse of COVID-19 testing to larger population via already available network of thousands of government and private facilities, that are equipped for this testing."

Arpan Malhotra, India Business Head - Diagnostics, Siemens Healthcare, Gurugram


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account